In short
Castleman disease is a rare lymphoproliferation with unicentric and multicentric forms needing tailored, often specialist, therapy.
What this guide covers: Overview · Diagnosis · Unicentric · Multicentric · Prognosis
Overview
Castleman disease is a rare disorder of lymph node tissue with two main forms: unicentric disease, involving a single node region, and multicentric disease, affecting many sites. Testing for HHV8 and HIV helps classify the disease. Idiopathic multicentric Castleman disease is managed differently from infection-associated forms.
Diagnosis
And Workup Evaluation includes a physical exam, blood counts, inflammatory markers, and protein studies. PET/CT imaging and virology testing are part of the standard workup. Doctors rule out conditions that mimic the disease, such as POEMS syndrome, lymphoma, and infection, before confirming the diagnosis.
Unicentric
Disease Localized disease is often treated with complete surgical removal, which can be curative. Unresectable cases may be managed with radiation, embolization, or careful observation.
Multicentric
Disease Multicentric disease requires systemic therapy guided by subtype and severity. Specialists consider HHV8, HIV, and organ function when selecting treatment. Relapsed or refractory cases use alternative regimens, and biopsy is encouraged to exclude transformation to lymphoma.
Prognosis
And Support Outcomes depend on subtype and how the disease responds to therapy. Fertility counseling and supportive care help manage the condition and its treatment effects.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.




